Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 41081801000001118 | Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 41081901000001112 | Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none | true | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Is a | Neostigmine 2.5mg/glycopyrronium 500mcg injection solution 1mL ampule | false | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Has active ingredient | Neostigmine methylsulfate | false | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Has active ingredient | Neostigmine | true | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Has active ingredient | Glycopyrronium bromide | true | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Has manufactured dose form | Injection | false | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Has manufactured dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Has specific active ingredient | Neostigmine methylsulfate | true | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Has specific active ingredient | Glycopyrronium bromide | false | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Has dispensed dose form | Conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Is a | Actual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Has specific active ingredient | Glycopyrronium bromide | true | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Is a | Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules | false | Inferred relationship | Existential restriction modifier | ||
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Is a | Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule | Is pack of | False | Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Inferred relationship | Existential restriction modifier | |
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule | Has AMP | True | Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR